| PODCASTS | VIDEO
- n the wake of amyloid beta, companies eye tau and neuroinflammation as Alzheimer’s drug targets. Live from Neuroscience 2019,
October 21, 2019
BY: Regina Kelder
- Alzheimer's disease is a type of dementia that causes problems with memory, thinking and behavior. Alzheimer's disease accounts for 60 percent to 80 percent of dementia cases.Alzheimer's has no current…
September 30, 2019
BY: Regina Kelder
- How antisense oligonucleotides are moving from obscurity to a viable drug strategy. Our live coverage of Neuroscience 2019 continues.
October 21, 2019
BY: Regina Kelder
- Human-derived models are an exciting alternative, but rodents are still relevant. Our coverage of Neuroscience 2019 continues
October 20, 2019
BY: Regina Kelder
- Research is growing in the links between neuroinflammation and a number of stubborn CNS diseases. Day one of our live Neuroscience 2019
October 20, 2019
BY: Regina Kelder
- The Society for Neuroscience meeting is getting underway this weekend. Charles River scientists discuss how automation is speeding up ion channel research
October 17, 2019
BY: Mary Parker

Microglial cells are the first defense immune cells in the brain. They might also be an important therapeutic target for future drugs. 

October 1, 2019
BY: Mary Parker
- Also: STDs rise in the US for the five year in a row, and hope for schizophrenia patients
October 11, 2019
BY: Mary Parker

Test Your Knowledge

Welcome to your STD

Twenty years ago, scientists from the Institute for Genomic Research in Maryland and the University of Texas Health Science Center published the full genome of what deadly sexually transmitted disease, known to Shakespeare as "the French disease"?


- How physicians and scientists teamed up for one little girl born with a deadly form of Batten disease
October 10, 2019
BY: Regina Kelder